Maria C. Carrillo

Physiatry
6515 Atlantic Ave
Bell, CA 90201

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 253 publications

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

Journal: Neurology
Published: August 26, 2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Journal: JAMA
Published: July 13, 2026

Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple Cohorts.

Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple Cohorts.

Journal: bioRxiv : the preprint server for biology
Published: July 03, 2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Journal: Lancet (London, England)
Published: May 13, 2026

Recent Cochrane review has serious flaws: A perspective of clinicians and researchers from around the world.

Recent Cochrane review has serious flaws: A perspective of clinicians and researchers from around the world.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 13, 2026

Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention: The POINTER Imaging Ancillary Study.

Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention: The POINTER Imaging Ancillary Study.

Journal: JAMA neurology
Published: April 20, 2026

Development and validation of a harmonized memory score for multicenter Alzheimer's disease and related dementia research.

Development and validation of a harmonized memory score for multicenter Alzheimer's disease and related dementia research.

Journal: Alzheimer's research & therapy
Published: March 19, 2026

Identification of patients receiving amyloid-targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS.

Identification of patients receiving amyloid-targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: March 18, 2026

Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals.

Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals.

Journal: Alzheimer's & dementia. Behavior & socioeconomics of aging
Published: March 12, 2026

The cost of dementia in the United States in 2026.

The cost of dementia in the United States in 2026.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 13, 2026

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 03, 2026
Showing 1-12 of 253

Last Updated: 09/26/2026